Horizon Pharma plc buy BiotechBee
Start price
07.09.22
/
70%
€61.22
Target price
31.12.25
€100.00
Performance (%)
73.41%
End price
14.12.22
€106.16
Summary
This prediction ended on 14.12.22 with a price of €106.16. With a performance of 73.41% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Horizon Pharma plc | - | - | - | - |
| iShares Core DAX® | -4.932% | -11.977% | -3.667% | 45.798% |
| iShares Nasdaq 100 | -2.634% | -2.218% | 14.638% | 78.685% |
| iShares Nikkei 225® | -4.733% | -10.900% | 19.738% | 45.866% |
| iShares S&P 500 | -2.544% | -3.540% | 9.339% | 58.518% |
According to BiotechBee what are the pros and cons of Horizon Pharma plc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Horizon Pharma plc diskutieren
Buy mit Kursziel 100,0